Scholarships

At GEICO we are committed to research and the fight against gynecological cancer. Each year, we announce several grants with the aim of promoting research in this field and improving the health of our patients.

Our grants are designed to support our researchers and their multidisciplinary teams who are working on innovative projects to understand and treat gynecologic cancer.

If you are a researcher interested in making a difference in the lives of women affected by gynecologic cancer, we invite you to submit your project for our annual grants.

25th ANNIVERSARY GEICO Grant for research in Gynecological Tumors
25th ANNIVERSARY GEICO Grants for research in Gynecological Tumors.
We are pleased to announce the opening of the call for two GEICO 25th Anniversary Gynecologic Tumor Research Grants.
In celebration of our 25th year of commitment to excellence in gynecologic oncology, we are excited to offer this unique opportunity to support innovative research projects in our field.
The grants are intended to fund promising research projects that contribute to the advancement of knowledge in the prevention, diagnosis, therapeutic management, follow-up and quality of life of patients affected by gynecological tumors.
Interested parties wishing to apply for the grant may send the application + project report to epuertas@grupogeico.net with a copy to secretariageico@grupogeico.org. The deadline for submission is June 30.
Andrés Poveda GEICO Translational Research Grant
Andrés Poveda 2024 GEICO Translational Research Grant.
We inform you that the deadline to apply for the GEICO Translational Research Grants "Andrés Poveda" 2024, which in this call have been launched thanks to the generous donation of GSK and AstraZeneca, is now open.
As in the last call, the research project must be original, of one year's duration and must be included in the translational research of any type of gynecological cancer. Two grants of €25,000 each will be awarded. Attached you will find all the information about the 2024 call for applications.
Those interested can fill in their application + scientific-technical report of the project (see attached form) and send it by e-mail to the addresssecretariageico@grupogeico.orgcon copy to epuertas@grupogeico.net indicating in the subject: Application for the "Andrés Poveda 2024 GEICO Translational Research Grant".
You can send your applications until June 30 at 23:59.

Grants awarded

2023 - Andres Poveda GEICO Translational Research Grant
Laura Costas / Jordi Ponce
Mutation analysis of circulating tumor DNA in urine samples for disease monitoring in endometrial cancer
2023 - Andres Poveda GEICO Translational Research Grant
Antonio Fernández / Jose Antonio López - Guerrero
Predictive study of response to immunotherapy in endometrial cancer based on the complete transcriptome study (SERENA).
2022 - Andres Poveda GEICO Translational Research Grant
Ainhoa Madariaga
Characterization of immune biomarkers in cervical carcinoma.
2022 - Andres Poveda GEICO Translational Research Grant
Arantzazu Barquin
Prospective observational study for the development of artificial intelligence algorithms capable of predicting the evolution of patients with advanced ovarian cancer by integrating their clinical, pathological and molecular characteristics.
2021 - Andres Poveda GEICO Translational Research Grant
Alejandro Pérez - Fidalgo
Analysis of AXL and its relationship with the immune system as a mechanism of resistance to PARP inhibitors in high-grade ovarian cancer.
2021 - Andres Poveda GEICO Translational Research Grant
Jordi Barretina / Margarita Romeo
Resistance to PARP inhibitors in ovarian cancer: identification of biomarkers using Single Cell technology.
2020 - Andres Poveda GEICO Translational Research Grant
Jose Antonio Lopez - Guerrero
Predictive model of response to DNA damaging agents and PARP inhibitors based on genomic scars (SCARFACE).
2020 - Andres Poveda GEICO Translational Research Grant
Marta Mendiola / Andrés Redondo
Identification of HRD markers and short-term prediction of response to PARP inhibitors in established cell lines and organoids derived from ovarian cancer patients.
2020 - Andres Poveda GEICO Translational Research Grant
Antonio González / Beatriz Tavira
Identification of markers associated with response to PARP inhibitors and immunotherapy in recurrent ovarian cancer.